sequence,half_life_seconds,experimental_characteristics,length_sequence,hl_category
RRWQWR,1800.0,Human serum,6,Low
AAGIGILTV,22.0,VMM5 cytotoxic T-lymphocyte line incubated in human plasma,9,Low
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,144.0,Intravenouly injected into male B6SJLF1/J mice and blood samples collected from tail vein to prepare plasma samples,40,Low
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,168.0,Intravenouly injected into male B6SJLF1/J mice and blood samples collected from tail vein to prepare plasma samples,42,Low
GVQLDLDEAI,4800.0,Intravenously injected in male New Zealand white rabbits and blood samples withdrawn  and plasma sample prepared,10,Low
PINPRLDG,900.0,Intravenously injected in male New Zealand white rabbits and blood samples withdrawn  and plasma sample prepared,8,Low
DGEQLADLIV,900.0,Intravenously injected in Male New Zealand white rabbits and blood samples withdrawn  and plasma sample prepared,10,Low
RQIKIWFQNRRMKWKKNELKRAFAALRDQI,43020.0,Fetal bovine serum batch1,30,High
SPKMMHKSGCFGRRLDRIGSLSGLGCNVLRKY,94.2,Injected intravenously into dogs,32,Low
YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ,21600.0,Human plasma,42,High
SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH,762.0,Infused in pulmonary artery of sheep,32,Low
MMRDSGCFGRRLDRIGSLSGLGCNVLRRY,156.0,Infused in pulmonary artery of sheep,29,Low
SLRRSSCFGGRMDRIGAQSGLGCNSFRY,180.0,Infused in pulmonary artery of sheep,28,Low
SPTLAYAVP,210.0,Human serum,9,Low
LW,444.0,Rat plasma,2,Low
SY,312.0,Rat plasma,2,Low
VY,900.0,Rat plasma,2,Low
LY,258.0,Rat plasma,2,Low
AY,564.0,Rat plasma,2,Low
YY,960.0,Rat plasma,2,Low
AD,3840.0,Rat plasma,2,Low
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT,600.0,Not reported,29,Low
MLTKFETKSARVKGLSFHPKRPWIL,9720.0,Mice plasma,25,Medium
FVPIFTYGELQRMQEKERNKGQ,198.0,Intravenouly injected in Sprague-Dawley rats,22,Low
FVPIFTYGELQRSPEHQRVQQRKESKKPPAKLQPR,702.0,Intravenouly injected in Sprague-Dawley rats,35,Low
FVPIFTYGELQREHQRVQQRKESKKPPAKLQPR,666.0,Intravenouly injected in Sprague-Dawley rats,33,Low
FVPIFTYGELQRQRVQQRKESKKPPAKLQPR,534.0,Intravenouly injected in Sprague-Dawley rats,31,Low
FVPIFTYGELQRVQQRKESKKPPAKLQPR,534.0,Intravenouly injected in Sprague-Dawley rats,29,Low
FVPIFTYGELQRQRKESKKPPAKLQPR,480.0,Intravenouly injected in Sprague-Dawley rats,27,Low
FVPIFTYGELQRKESKKPPAKLQPR,564.0,Intravenouly injected in Sprague-Dawley rats,25,Low
FVPIFTYGELQRSKKPPAKLQPR,318.0,Intravenouly injected in Sprague-Dawley rats,23,Low
FVPIFTYGELQRKKPPAKLQPR,360.0,Intravenouly injected in Sprague-Dawley rats,22,Low
FVPIFTYGELQRVQQRKESKKPPAKLQ,624.0,Intravenouly injected in Sprague-Dawley rats,27,Low
FVPIFTYGELQRVQQRKESKKPPAK,348.0,Intravenouly injected in Sprague-Dawley rats,25,Low
FVPIFTYGELQRVQQRKESKKPP,378.0,Intravenouly injected in Sprague-Dawley rats,23,Low
FVPIFTYGELQRVQQRKESKK,420.0,Intravenouly injected in Sprague-Dawley rats,21,Low
FVPIFTYGELQRVQQRKES,186.0,Intravenouly injected in Sprague-Dawley rats,19,Low
FVPIFTYGELQRVQQRK,144.0,Intravenouly injected in Sprague-Dawley rats,17,Low
HADGSFSDEMNTILDNLAARDFINWLIQTKITD,408.0,Infused into blood of pigs,33,Low
TSEKSQTPLVTL,16200.0,SVK14 keratinocytes,12,Medium
DRVYIHP,10.0,Blood sample of normotensive Sprague-Dawley rat,7,Low
EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ,2010.0,6 Normal human male blood plasma sample,31,Low
GRGDS,480.0,Blood sample of C57BL/6 mice,5,Low
RPPGF,5400.0,"Intravenous injection of Bradykinin,Human blood sample",5,Low
APRLRFYSL,1560.0,Heamolymph of Aplysia,9,Low
PRLRFYSL,3840.0,Heamolymph of Aplysia,8,Low
APRLRFYS,1620.0,Heamolymph of Aplysia,8,Low
APRLRF,660.0,Heamolymph of Aplysia,6,Low
APRLR,960.0,Heamolymph of Aplysia,5,Low
RLRFYSL,126.0,Heamolymph of Aplysia,7,Low
LRFYSL,162.0,Heamolymph of Aplysia,6,Low
RFYSL,90.0,Heamolymph of Aplysia,5,Low
FYSL,39.0,Heamolymph of Aplysia,4,Low
YSL,582.0,Heamolymph of Aplysia,3,Low
RLRFYS,90.0,Heamolymph of Aplysia,6,Low
LRFYS,90.0,Heamolymph of Aplysia,5,Low
FYS,28.8,Heamolymph of Aplysia,3,Low
DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV,3240.0,Human  blood plasmaMale patients with stable congestive heart failure  Intravenous injection,40,Low
ELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSPEDSSPDAARIRV,1320.0,Human blood plasma,48,Low
TVPVDLASRQEEEEQSPDSTEEEPVTLPR,3780.0,pMEP-E2 CV-1 cell lines,29,Low
TVPVDLASRQEEEEQSADSTEEEPVTLPR,5640.0,pMEP-E2 CV-1 cell lines,29,Low
TVPVDLASRQEEEEQSPDSTEQEPVTLPR,1440.0,pMEP-E2 CV-1 cell lines,29,Low
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,34452.0,Human blood plasma,39,High
IPP,1800.0,Human blood plasma oral,3,Low
SLRRSSCFGGRIDRIGAQSGCNSFRY,144.0,Human blood plasma,26,Low
HSDAVFTDNYTRLRKQMAVKKYLNSILN,4968.0,Rat lung alveolar L2 cells,28,Low
HSDAVFTDNYTRLRRQMLVRRYLNSILNGRR,17028.0,Rat lung alveolar L2 cells,31,Medium
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,31680.0,Male cynomolgus monkey blood plasma Intravenous,36,High
WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF,21240.0,Male cynomolgus monkey blood plasma Intravenous,39,High
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL,1080.0,Male cynomolgus monkey blood plasma Intravenous,36,Low
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL,4320.0,Male cynomolgus monkey blood plasma Intravenous,38,Low
TTWEAWDRAIAEYAARIEALIRASQEQQEKNEAELREL,4320.0,Male cynomolgus monkey blood plasma Intravenous,38,Low
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,58680.0,Male cynomolgus monkey blood plasma Intravenous,38,High
MTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,18360.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAILREL,12240.0,Male cynomolgus monkey blood plasma Intravenous,38,Medium
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAALREL,54720.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL,27360.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAILREL,44640.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAALREL,64440.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAVLREL,102960.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL,30960.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAILREL,34560.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRAAQELQEKLEAALREL,110880.0,Male cynomolgus monkey blood plasma Intravenous,38,High
TTWEAWDRAIAEYAARIEALIRALQELQEKLEAILREL,127440.0,Male cynomolgus monkey blood plasma Intravenous,38,High
SPRGDLAVLGHKY,3300.0,Human serum,13,Low
YGRKKRRQRRR,24000.0,Human plasma,11,High
HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIA,6120.0,Mouse plasma Subcutaneous injection,37,Low
LEQYANQLADQIIKEATE,5400.0,Human serum,18,Low
NPVENMMDRDSQ,43200.0,Human plasma,12,High
HAECTFTSDVSSYLEGQAAKEFIAWLCKGRGCPSSGAPPPSGGGGG,172800.0,Serum of rats Subcutaneous injection,46,High
MAPRGFSCLLLLTGEIDLPVKRRA,1800.0,Mice plasma,24,Low
KPTFRRLKWK,1020.0,Fetal calf serum,10,Low
EAAGIGILTV,2700.0,Serum human,10,Low
FVPIFTYGELQREHQRVQQQRKESKKPPAKLQPR,668.4,Rat plasma Intravenous,34,Low
FVPIFTYGELQRQRVQQRKESKKPPAK,345.6,Rat plasma Intravenous,27,Low
FVPIFTYGELQRQRVQQRKESKKPP,380.4,Rat plasma Intravenous,25,Low
FVPIFTYGELQRQRVQQRKESKK,368.4,Rat plasma Intravenous,23,Low
FVPIFTYGELQRQRVQQRKES,293.4,Rat plasma Intravenous,21,Low
FVPIFTYGELQRQRVQQRK,143.4,Rat plasma Intravenous,19,Low
FVPIFTYGELQRVQQRKEKKPPAKLQPR,547.2,Rat plasma Intravenous,28,Low
FVPIFTYGELQRVQQRKEFKKPPAKLQPR,463.8,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKETKKPPAKLQPR,580.2,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKEPKKPPAKLQPR,579.0,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKELKKPPAKLQPR,547.8,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKEAKKPPAKLQPR,557.4,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKQSKKPPAKLQPR,339.6,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKDSKKPPAKLQPR,608.4,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKKKPPAKLQPR,323.4,Rat plasma Intravenous,27,Low
FVPIFTYGELQRVQQKRDSRRPPAKLQPR,473.4,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQKKSEKRPPAKLQPR,696.0,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKGESKKPPAKLQPR,631.8,Rat plasma Intravenous,30,Low
FVPIFTYGELQRQQRKESGKKPPAKLQPR,693.0,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKGGESKKPPAKLQPR,690.0,Rat plasma Intravenous,31,Low
FVPIFTYGELQRVQQRKESKKAKLQPR,463.8,Rat plasma Intravenous,27,Low
FVPIFTYGELQRVQQRKESKKAKLAALKA,536.4,Rat plasma Intravenous,29,Low
FVPIFTYGELQRVQQRKESKKPPAKLAALKA,596.4,Rat plasma Intravenous,31,Low
FVPIFTYGELQRVQQRKESKKPPAELAALEA,766.8,Rat plasma Intravenous,31,Low
FVPIFTYGELQRVQQRKESKKPPAELAALKA,693.6,Rat plasma Intravenous,31,Low
FVPIFTYGELQRVQQRKESKKMITIR,263.4,Rat plasma Intravenous,26,Low
FVPIFTYGELQRVQQRKESKKPPMITIR,315.0,Rat plasma Intravenous,28,Low
FVPIFTYGELQRKESKKPAKLAALKA,617.4,Rat plasma Intravenous,26,Low
FVPIFTYGELQRVQQKKAYSPDKERKPPALQPR,781.8,Rat plasma Intravenous,33,Low
FVPIFTYGELQRVQQKKAYSPDKERKPPAKLQPR,785.4,Rat plasma Intravenous,34,Low
HGDGSFSDEMNTILDNLAARDFINWLIQTLITDK,58320.0,Rat plasma Intravenous,34,High
VKFNKPFVFLMIEQNTK,6840.0,Rat plasma Intravenous,17,Low
KGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY,5400.0,Rat plasma Intravenous,39,Low
HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,162000.0,Monkey plasma Intravenous,31,High
HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG,198000.0,Dog plasma Intravenous,31,High
HVEGTFTSDVSSYLEEQAAKEFIAWLIKGGPSSGAPPPCC,92880.0,Rat plasma Intravenous,40,High
HVEGTFTSDVSSYLEEQAAKEFIAWLIKGGPSSGAPPPC,129600.0,Rat plasma Intravenous,39,High
SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII,3756.0,Rat plasma Subcutaneous,41,Low
ELYENKPRRPYIL,354.0,Rat serum,13,Low
YGGFL,1272.0,Human plasma mixed with drug Thioridazine,5,Low
HADGVFTSDFSRLLGQLSAKKYLESLI,186.0,Intravenous administration to human plasma,27,Low
ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,414.0,Intravenous injection into human,37,Low
GGFMTSEKSQTPLVTL,42.0,Male wistar Rats intravenously,16,Low
MKAIFVLKGWWRTS,210.0,Not reported,14,Low
SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA,972.0,Intravenous administration to human plasma,41,Low
ADSGEGDFLAEGGGVR,30.0,Intravenous injection in lateral vein of normal rabbit,16,Low
VPLPAGGGTVLTKMYPRGNHWAVGHLM,168.0,Human serum,27,Low
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,144.0,Intravenous injection to dogs plasma,31,Low
NSPR,13380.0,Subcutaneously injected to rat,4,Medium
VVVPP,36000.0,Intravenous administration to human,5,High
AQDFVQWLMNT,10.0,Hepatic plasma membrane,11,Low
CSCSSLMDKECVYFCHLDIIWVNTPEHVVPYGLGSPRS,86400.0,Purified ET-1 protein sample,38,High
CSCSSLMDKECVYFCHLDIIW,2220.0,Purified ET-1 protein sample,21,Low
VNTPEHVVPYGLGSPRS,3420.0,Purified ET-1 protein sample,17,Low
CSCSSLMDKECVYFCHLDIIWVNTPERVVPYGLGSPSRS,1500.0,Purified ET-1 protein sample,39,Low
VNTPERVVPYGLGSPSRS,2820.0,Purified ET-1 protein sample,18,Low
RPKPQQFFGLM,126.0,Purified ET-1 protein sample,11,Low
GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS,222.0,Human serum,30,Low
DGGFL,1272.0,Nasal administration to Male Sprague Dawley derived rats,5,Low
EAKSQGGSN,150.0,Intravenouly injected in male Wistar rats,9,Low
SYSMEHFRWGKPVGKKRRPVKVYPAGEDDEASEAFPLEF,439.2,Intravenously injected to rat,39,Low
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,300.0,Subcutaneously injected in mice,37,Low
FGGFTGARKSARKLANQ,3840.0,Mouse Plasma,17,Low
AEIYNKDGNKLDLYG,1800.0,Buffer,15,Low
VDKPPYLPRPRPPRRIYN,7200.0,25% mouse serum,18,Low
DRVYIHPFHL,3600.0,Bacterial strain B-9 cell culture,10,Low
YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE,300.0,Bacterial strain B-9 cell culture,31,Low
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRPSSGAPPPS,1170.0,Bolus injectionPig kidney,39,Low
MIFVKTLTGKTIL,5400.0,Sprague Dawley rats Dose i/m injected,13,Low
PLLQATL,5400.0,Human plasma,7,Low
HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY,250.8,Protein Sample +HAS + Fxa +DPP IV,31,Low
MWQRPSSWIEGRFPHSDAVFTDQYTRLRKQLAAKKYLQSLKQKRY,34956.0,Buffer containing peptide sample,45,High
YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY,12240.0,Female pigs blood + Peptide sample+ DPP-IV inhibitor valine pyrrolidide,36,Medium
LLTHTISRIAVSYQTKVNLL,345.6,BALB/c mice plasma Dose i/v injected,20,Low
MWQRPSSWIEGRLLTHTISRIAVSYQTKVNLL,47196.0,BALB/c mice plasma Dose i/v injected,32,High
GPE,300.0,Sprague-Dawley rats plasma Dose i/v injected,3,Low
RKEVY,30.0,Human plasma,5,Low
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,3600.0,Western Blotting,37,Low
SQEPPISLVLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA,2568.0,Sheep plasma,41,Low
GWTLNSAGYLLGPHAI,1680.0,Hypothalamic membranes of Male Sprague-Dawley rats,16,Low
HADGVFTSDFSKLLGQLSAKKYLESLMGKRVSSNISEDPVPV,2250.0,Human plasma,42,Low
HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA,720.0,Human plasma Dose i/v injected,37,Low
YGGFM,768.0,Human plasma,5,Low
WAGGDASGE,434.4,Mongrel dog plasmaDose i/v injected,9,Low
AGGDASGE,453.0,Mongrel dog plasmaDose i/v injected,8,Low
APGPR,300.0,Human Serum,5,Low
YDPAPPPPPP,5760.0,A. aegypti blood,10,Low
PGDSTRKCMDLKGNK,3240.0,Human plamsa,15,Low
SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF,18000.0,Human plasma Severe renal impairment patients,34,Medium
RKDVY,336.0,heparinized rabbit plasma,5,Low
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWC,2340.0,Solutions of bovine trypsin and the peptide or PEG−peptide conjugate in 10 mM PBS pH 7.4,42,Low
HGDGSFSDEMNTILDNLAARDFINWLIQTKITDK,138600.0,Subcutaneous injection in female Sprague – Dawley strain rats,34,High
RREAQNPQAGAVELGGGLGGLNALALEGPPQKRG,594.0,Porcine blood,34,Low
GGFL,780.0,Sheep nasal wash fluid,4,Low
GCRFGTCT,67.5,Hind limb vascular bed of the cat,8,Low
